Skip to content
Screener

Ironwood Pharmaceuticals IRWD Total Liabilities

Total Liabilities at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$25.58B-4.1%
Ardelyx logo
ArdelyxARDX
$426.88M+30.4%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$104.71M-33.5%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$1.06B+124%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.55B+8.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.5B+30.1%

Other financials

Income statement

See full
Revenue$113.0M+32.6%
Operating income$79.3M+75.0%
Net income$51.3M+117%
EPS (diluted)$0.31+121%

Balance sheet

See full
Cash & equivalents$79.1M-14.8%
Total debt$11.9M-94.4%
Total equity-$161.8M+47.5%
Total assets$285.1M-16.9%

Cash flow

See full
Operating cash flow$58.3M—
CapEx-—
Free cash flow$74.6M+390%

Valuation

See full
Market cap$669.22M+395%
Enterprise value$601.96M+135%
P/E5.2×—
P/S1.7×+1.3×

Profitability

See full
Gross margin99.2%—
Operating margin60.1%+36.4pp
Net margin33.4%+31.1pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity0×-0.5×
Current ratio6.1×+5.2×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-091987

FAQ

What is Ironwood Pharmaceuticals's total liabilities?
Ironwood Pharmaceuticals (IRWD) reported total liabilities of $446.97M in Q2 2026.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Ironwood Pharmaceuticals's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude